Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat

Retrovirology

Volumn 5, Issue , 2008, Pages

  Jadlowsky, Julie K ^a   Nojima, Masanori ^a   Schulte, Antje ^b   Geyer, Matthias ^b   Okamoto, Takashi ^c   Fujinaga, Koh ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN T1; MUTANT PROTEIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEASOME INHIBITOR; TRANSACTIVATOR PROTEIN; CCNT1 PROTEIN, HUMAN; CYCLINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SEQUENCE ALIGNMENT; STEADY STATE; VIRUS MUTATION; VIRUS TRANSCRIPTION; WILD TYPE; ANIMAL; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOUSE; MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; CYCLINS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HIV-1; HUMANS; MICE; MUTATION; NIH 3T3 CELLS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC;

EID: 48649095343     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-63     Document Type: Article

References (46)

1. Karn J Tackling Tat J Mol Biol 1999, 293:235-254. 10.1006/jmbi.1999.3060 10550206
2. Taube R Fujinaga K Wimmer J Barboric M Peterlin BM Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation Virology 1999, 264:245-253. 10.1006/viro.1999.9944 10562489
3. Bieniasz PD Grdina TA Bogerd HP Cullen BR Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat Embo J 1998, 17:7056-7065. 1171053 9843510 10.1093/emboj/17.23.7056
4. Fujinaga K Taube R Wimmer J Cujec TP Peterlin BM Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T Proc Natl Acad Sci USA 1999, 96:1285-1290. 15455 9990016 10.1073/ pnas.96.4.1285
5. Garber ME Wei P KewalRamani VN Mayall TP Herrmann CH Rice AP Littman DR Jones KA The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein Genes Dev 1998, 12:3512-3527. 317238 9832504 10.1101/ gad.12.22.3512
6. Kim YK Bourgeois CF Isel C Churcher MJ Karn J Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation Mol Cell Biol 2002, 22:4622-4637. 133925 12052871 10.1128/ MCB.22.13.4622-4637.2002
7. Peng J Zhu Y Milton JT Price DH Identification of multiple cyclin subunits of human P-TEFb Genes Dev 1998, 12:755-762. 316581 9499409 10.1101/gad.12.5.755
8. Kwak YT Ivanov D Guo J Nee E Gaynor RB Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation J Mol Biol 1999, 288:57-69. 10.1006/jmbi.1999.2664 10329126
9. Ivanov D Kwak YT Nee E Guo J Garcia-Martinez LF Gaynor RB Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation J Mol Biol 1999, 288:41-56. 10.1006/jmbi.1999.2663 10329125
10. Zhang J Tamilarasu N Hwang S Garber ME Huq I Jones KA Rana TM HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1 J Biol Chem 2000, 275:34314-34319. 10.1074/jbc.M006804200 10944537
11. Zhou Q Yik JH The Yin and Yang of P-TEFb regulation: Implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation Microbiol Mol Biol Rev 2006, 70:646-659. 1594588 16959964 10.1128/MMBR.00011-06
12. Michels AA Fraldi A Li Q Adamson TE Bonnet F Nguyen VT Sedore SC Price JP Price DH Lania L Bensaude O Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor Embo J 2004, 23:2608-2619. 449783 15201869 10.1038/sj.emboj.7600275
13. Michels AA Nguyen VT Fraldi A Labas V Edwards M Bonnet F Lania L Bensaude O MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner Mol Cell Biol 2003, 23:4859-4869. 162212 12832472 10.1128/MCB.23.14.4859-4869.2003
14. Barboric M Yik JH Czudnochowski N Yang Z Chen R Contreras X Geyer M Matija Peterlin B Zhou Q Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription Nucleic Acids Res 2007, 35:2003-2012. 1874611 17341462 10.1093/nar/gkm063
15. Schulte A Czudnochowski N Barboric M Schonichen A Blazek D Peterlin BM Geyer M Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat J Biol Chem 2005, 280:24968-24977. 10.1074/jbc.M501431200 15855166
16. Bieniasz PD Grdina TA Bogerd HP Cullen BR Recruitment of cyclin T1/ P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription Proc Natl Acad Sci USA 1999, 96:7791-7796. 22140 10393900 10.1073/pnas.96.14.7791
17. Garber ME Wei P Jones KA HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA Cold Spring Harb Symp Quant Biol 1998, 63:371-380. 10.1101/sqb.1998.63.371 10384302
18. Anand K Schulte A Fujinaga K Scheffzek K Geyer M Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat J Mol Biol 2007, 370:826-836. 10.1016/j.jmb.2007.04.077 17540406
19. Dames SA Schonichen A Schulte A Barboric M Peterlin BM Grzesiek S Geyer M Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb Proc Natl Acad Sci USA 2007, 104:14312-14317. 1955226 17724342 10.1073/pnas.0701848104
20. Mancebo HS Lee G Flygare J Tomassini J Luu P Zhu Y Peng J Blau C Hazuda D Price D Flores O P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro Genes Dev 1997, 11:2633-2644. 316604 9334326 10.1101/gad.11.20.2633
21. Mischiati C Jeang KT Feriotto G Breda L Borgatti M Bianchi N Gambari R Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA Antisense Nucleic Acid Drug Dev 2001, 11:209-217. 10.1089/108729001317022214 11572598
22. Lind KE Du Z Fujinaga K Peterlin BM James TL Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA Chem Biol 2002, 9:185-193. 10.1016/ S1074-5521(02)00106-0 11880033
23. Chao SH Fujinaga K Marion JE Taube R Sausville EA Senderowicz AM Peterlin BM Price DH Flavopiridol inhibits P-TEFb and blocks HIV-1 replication J Biol Chem 2000, 275:28345-28348. 10.1074/jbc.C000446200 10906320
24. Richter SN Palu G Inhibitors of HIV-1 Tat-mediated transactivation Curr Med Chem 2006, 13:1305-1315. 10.2174/092986706776872989 16712471
25. Heredia A Davis C Bamba D Le N Gwarzo MY Sadowska M Gallo RC Redfield RR Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication Aids 2005, 19:2087-2095. 16284457
26. Hwang S Tamilarasu N Kibler K Cao H Ali A Ping YH Jeang KT Rana TM Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication J Biol Chem 2003, 278:39092-39103. 10.1074/jbc.M301749200 12857725
27. Okamoto H Cujec TP Okamoto M Peterlin BM Baba M Okamoto T Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37 Virology 2000, 272:402-408. 10.1006/viro.2000.0396 10873784
28. Yedavalli VS Benkirane M Jeang KT Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1 J Biol Chem 2003, 278:6404-6410. 10.1074/jbc.M209162200 12458222
29. Napolitano G Mazzocco A Fraldi A Majello B Lania L Functional inactivation of Cdk9 through oligomerization chain reaction Oncogene 2003, 22:4882-4888. 10.1038/sj.onc.1206785 12894230
30. Fujinaga K Irwin D Geyer M Peterlin BM Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression J Virol 2002, 76:10873-10881. 136629 12368330 10.1128/ JVI.76.21.10873-10881.2002
31. Hoque M Tian B Mathews MB Pe'ery T Granulin and granulin repeats interact with the Tat.P-TEFb complex and inhibit Tat transactivation J Biol Chem 2005, 280:13648-13657. 10.1074/jbc.M409575200 15653695
32. Hoque M Young TM Lee CG Serrero G Mathews MB Pe'ery T The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription Mol Cell Biol 2003, 23:1688-1702. 151712 12588988 10.1128/ MCB.23.5.1688-1702.2003
33. Young TM Wang Q Pe'ery T Mathews MB The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription Mol Cell Biol 2003, 23:6373-6384. 193714 12944466 10.1128/ MCB.23.18.6373-6384.2003
34. Bai J Sui J Zhu RY Tallarico AS Gennari F Zhang D Marasco WA Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies J Biol Chem 2003, 278:1433-1442. 10.1074/ jbc.M208297200 12401780
35. Chao SH Price DH Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo J Biol Chem 2001, 276:31793-31799. 10.1074/jbc.M102306200 11431468
36. Wei P Garber ME Fang SM Fischer WH Jones KA A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA Cell 1998, 92:451-462. 10.1016/S0092-8674(00)80939-3 9491887
37. Kurosu T Peterlin BM VP16 and ubiquitin; binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes Curr Biol 2004, 14:1112-1116. 10.1016/j.cub.2004.06.020 15203006
38. Fujinaga K Irwin D Taube R Zhang F Geyer M Peterlin BM A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells J Virol 2002, 76:12934-12939. 136680 12438619 10.1128/JVI.76.24.12934-12939.2002
39. Taube R Fujinaga K Irwin D Wimmer J Geyer M Peterlin BM Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1 J Virol 2000, 74:892-898. 111610 10623752 10.1128/JVI.74.2.892-898.2000
40. Garriga J Grana X Cellular control of gene expression by T-type cyclin/ CDK9 complexes Gene 2004, 337:15-23. 10.1016/j.gene.2004.05.007 15276198
41. Peterlin BM Price DH Controlling the elongation phase of transcription with P-TEFb Mol Cell 2006, 23:297-305. 10.1016/j.molcel.2006.06.014 16885020
42. Kim YK Bourgeois CF Pearson R Tyagi M West MJ Wong J Wu SY Chiang CM Karn J Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency Embo J 2006, 25:3596-3604. 1538560 16874302 10.1038/sj.emboj.7601248
43. Fujinaga K Irwin D Huang Y Taube R Kurosu T Peterlin BM Dynamics of Human Immunodeficiency Virus Transcription: P-TEFb Phosphorylates RD and Dissociates Negative Effectors from the Transactivation Response Element Mol Cell Biol 2004, 24:787-795. 343783 14701750 10.1128/ MCB.24.2.787-795.2004
44. Dull T Zufferey R Kelly M Mandel RJ Nguyen M Trono D Naldini L A third-generation lentivirus vector with a conditional packaging system J Virol 1998, 72:8463-8471. 110254 9765382
45. Tyagi M Karn J CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency EMBO J 2007, 26:4985-4995. 10.1038/ sj.emboj.7601928 18007589
46. Naldini L Blomer U Gallay P Ory D Mulligan R Gage FH Verma IM Trono D In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996, 272:263-267. 10.1126/ science.272.5259.263 8602510